Discovery of quinoline-based irreversible BTK inhibitors-MedSci.cn

Discovery of quinoline-based irreversible BTK inhibitors

de Bruin, G; Demont, D; de Zwart, E; Verkaik, S; Hoogenboom, N; van de Kar, B; van Lith, B; Emmelot-van Hoek, M; Gulrajani, M; Covey, T; Kaptein, A; Barf, T

de Bruin, G (corresponding author), Acerta Pharma BV, Kloosterstr 9, NL-5349 AB Oss, Netherlands.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020; 30 (14):

科室
- - 订阅+
  - 更多科室
工具
服务